CRL
Charles River Laboratories International, Inc.
Platform & Compounding FCF
C-
49.8 / 100 composite
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
-
5yr Avg ROIC
5.6%
-
Operating Margin Trend
-1.88 pp/yr
-
5yr Avg ROE
8.1%
-
5yr Share-Count CAGR
-0.4%
-
5yr Revenue CAGR
6.6%
-
Revenue-Growth Years (5)
3/5
-
5yr FCF Margin
11.3%
-
5yr FCF/NI Conversion
12.86x
-
Net Debt / EBITDA
6.94x
-
Interest Coverage (EBIT/Int)
0.07x
-
Altman Z-Score
3.14
Stability
Weight: 5%
D
39
-
EPS Volatility (σ/μ)
0.59
-
Negative-Revenue Years (5)
2/5
-
Piotroski F-Score
4
2 of 3 gurus held; 1 added; 1 trimmed; 3 full exits.
- Holders
- 2
-1
- Avg Δ position
-
-31.4%
- New buys
- 0
- Full exits
- 3